Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 29

1.

Novel phylogenetic algorithm to monitor human tropism in Egyptian H5N1-HPAIV reveals evolution toward efficient human-to-human transmission.

Perovic VR, Muller CP, Niman HL, Veljkovic N, Dietrich U, Tosic DD, Glisic S, Veljkovic V.

PLoS One. 2013 Apr 26;8(4):e61572. doi: 10.1371/journal.pone.0061572.

2.

Identification of hemagglutinin structural domain and polymorphisms which may modulate swine H1N1 interactions with human receptor.

Veljkovic V, Niman HL, Glisic S, Veljkovic N, Perovic V, Muller CP.

BMC Struct Biol. 2009 Sep 28;9:62. doi: 10.1186/1472-6807-9-62.

3.

Oncogene-related serum proteins and cancer risk: a nested case-control study.

Weissfeld JL, Larsen RD, Niman HL, Kuller LH.

Am J Epidemiol. 1996 Oct 15;144(8):723-7.

4.

p21 ras-related protein levels depend on sample handling.

Panson AJ, Niman HL, Weissfeld JL, Wu Y, Kuller LH.

Cancer Epidemiol Biomarkers Prev. 1994 Apr-May;3(3):281-2. No abstract available.

5.

Evaluation of oncogene-related proteins in serum.

Weissfeld JL, Larsen RD, Niman HL, Kuller LH.

Cancer Epidemiol Biomarkers Prev. 1994 Jan-Feb;3(1):57-62.

6.
7.

Protein binding, sister chromatid exchange and expression of oncogene proteins in patients treated with cisplatinum (cisDDP)-based chemotherapy.

Perera F, Fischman HK, Hemminki K, Brandt-Rauf P, Niman HL, Smith S, Toporoff E, O'Dowd K, Tang MX, Tsai WY, et al.

Arch Toxicol. 1990;64(5):401-6.

PMID:
2144958
8.

Serum oncogene proteins in foundry workers.

Brandt-Rauf PW, Smith S, Perera FP, Niman HL, Yohannan W, Hemminki K, Santella RM.

J Soc Occup Med. 1990 Spring;40(1):11-4.

PMID:
2139149
9.

Use of monoclonal antibodies as probes for oncogene products.

Niman HL.

Immunol Ser. 1990;53:189-204. Review. No abstract available.

PMID:
2100555
10.

Monoclonal antibodies to oncogene products.

Niman HL.

Prog Clin Biol Res. 1989;288:35-52. Review. No abstract available.

PMID:
2654954
11.

Serum oncogene proteins in hazardous-waste workers.

Brandt-Rauf PW, Smith S, Niman HL, Goldstein MD, Favata E.

J Soc Occup Med. 1989 Winter;39(4):141-3.

PMID:
2533643
12.

Serum screening for oncogene proteins in workers exposed to PCBs.

Brandt-Rauf PW, Niman HL.

Br J Ind Med. 1988 Oct;45(10):689-93.

13.

Expression of p21ras in normal and malignant human tissues: lack of association with proliferation and malignancy.

Chesa PG, Rettig WJ, Melamed MR, Old LJ, Niman HL.

Proc Natl Acad Sci U S A. 1987 May;84(10):3234-8.

14.

Human oncogene-related proteins in urine during pregnancy and neoplasia.

Niman HL.

Clin Lab Med. 1986 Mar;6(1):181-96. Review.

PMID:
3514097
15.

Anti-peptide antibodies detect oncogene-related proteins in urine.

Niman HL, Thompson AM, Yu A, Markman M, Willems JJ, Herwig KR, Habib NA, Wood CB, Houghten RA, Lerner RA.

Proc Natl Acad Sci U S A. 1985 Dec;82(23):7924-8.

16.

Blockade of autocrine stimulation in simian sarcoma virus-transformed cells reverses down-regulation of platelet-derived growth factor receptors.

Garrett JS, Coughlin SR, Niman HL, Tremble PM, Giels GM, Williams LT.

Proc Natl Acad Sci U S A. 1984 Dec;81(23):7466-70.

17.

Detection of high molecular weight forms of platelet-derived growth factor by sequence-specific antisera.

Niman HL, Houghten RA, Bowen-Pope DF.

Science. 1984 Nov 9;226(4675):701-3.

PMID:
6494905
18.

The structure of an antigenic determinant in a protein.

Wilson IA, Niman HL, Houghten RA, Cherenson AR, Connolly ML, Lerner RA.

Cell. 1984 Jul;37(3):767-78.

PMID:
6204768
19.

Proteins of the sea urchin egg vitelline layer.

Niman HL, Hough-Evans BR, Vacquier VD, Britten RJ, Lerner RA, Davidson EH.

Dev Biol. 1984 Apr;102(2):390-401.

PMID:
6200373
Items per page

Supplemental Content

Loading ...
Support Center